-
1
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound B
-
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound B. Ann Neurol 2004;55:306-319.
-
(2004)
Ann Neurol
, vol.55
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
-
2
-
-
0032989712
-
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
-
Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-368.
-
(1999)
Ann Neurol
, vol.45
, pp. 358-368
-
-
Price, J.L.1
Morris, J.C.2
-
3
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
-
4
-
-
79956084514
-
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7: 270-279.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 270-279
-
-
Albert, M.S.1
Dekosky, S.T.2
Dickson, D.3
-
5
-
-
84881476667
-
The A4 trial: Anti-amyloid treatment of asymptomatic Alzheimer's disease
-
Sperling R, DonohueM, Aisen P. The A4 trial: anti-amyloid treatment of asymptomatic Alzheimer's disease. Alzheimers Dement 2012;8:P425-P426.
-
(2012)
Alzheimers Dement
, vol.8
-
-
Sperling, R.1
Donohue, M.2
Aisen, P.3
-
6
-
-
84888228877
-
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity
-
Jack CR Jr, Wiste HJ, Weigand SD, et al. Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology 2013;81:1732-1740.
-
(2013)
Neurology
, vol.81
, pp. 1732-1740
-
-
Jack Jr., C.R.1
Wiste, H.J.2
Weigand, S.D.3
-
7
-
-
77649314191
-
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
-
Morris JC, Roe CM, Xiong C, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 2010;67:122-131.
-
(2010)
Ann Neurol
, vol.67
, pp. 122-131
-
-
Morris, J.C.1
Roe, C.M.2
Xiong, C.3
-
8
-
-
77954033257
-
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
-
Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010;31: 1275-1283.
-
(2010)
Neurobiol Aging
, vol.31
, pp. 1275-1283
-
-
Rowe, C.C.1
Ellis, K.A.2
Rimajova, M.3
-
9
-
-
55449111089
-
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence
-
Garibotto V, Borroni B, Kalbe E, et al. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology 2008;71:1342-1349.
-
(2008)
Neurology
, vol.71
, pp. 1342-1349
-
-
Garibotto, V.1
Borroni, B.2
Kalbe, E.3
-
10
-
-
84895642075
-
Cholinergic activity correlates with reserve proxies in Alzheimer's disease
-
Garibotto V, Tettamanti M, Marcone A, et al. Cholinergic activity correlates with reserve proxies in Alzheimer's disease. Neurobiol Aging 2013;34:e2613-e2698.
-
(2013)
Neurobiol Aging
, vol.34
-
-
Garibotto, V.1
Tettamanti, M.2
Marcone, A.3
-
11
-
-
84859406520
-
Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: Head-to-head comparison
-
Caroli A, Prestia A, Chen K, et al. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med 2012;53:592-600.
-
(2012)
J Nucl Med
, vol.53
, pp. 592-600
-
-
Caroli, A.1
Prestia, A.2
Chen, K.3
-
12
-
-
84862767786
-
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
-
Jack CR Jr, Knopman DS, Weigand SD, et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 2012;71:765-775.
-
(2012)
Ann Neurol
, vol.71
, pp. 765-775
-
-
Jack Jr., C.R.1
Knopman, D.S.2
Weigand, S.D.3
-
13
-
-
84858019144
-
The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging
-
Roberts RO, Geda YE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 2012;78:342-351.
-
(2012)
Neurology
, vol.78
, pp. 342-351
-
-
Roberts, R.O.1
Geda, Y.E.2
Knopman, D.S.3
-
14
-
-
80955137862
-
Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia
-
Klunk WE. Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging 2011;32:S20-S36.
-
(2011)
Neurobiol Aging
, vol.32
-
-
Klunk, W.E.1
|